Jacob P. Lalezari
Head of Research and Translational SciencesDr. Jacob P. Lalezari, also known as Jay, MD, was Interim Chief Executive Officer at CytoDyn Inc. since November 17, 2023 until January 26, 2024 and served as it's Chief Executive Officer and principal executive officer since January 26, 2024 until October 20, 2026 and is its Head of Research and Translational Sciences from October 20, 2026. He served as an Interim Chief Medical Officer at CytoDyn Inc. since March 2020 until November 2020. He served as Member of Scientific Advisory Board at CytoDyn Inc. He has been the CEO and Medical Director of Lalezari Medical Corp., dba Quest Clinical Research since 1997, a company he founded in 1989. He serves as an Assistant Clinical Professor of Medicine at UCSF/Mount Zion Hosp HSV, Hepatitis B ital. Dr. Lalezari has also served as a board member and Medical Director of Siempre Unidos. Dr. Lalezari served as Co-Director of the HIV Clinical Research Center at Mt. Zion Medical Center and also at the University of California in San Francisco. Since 2006, he was the Chief Medical Officer of Virion Therapeutics, LLC, in 2018 and a board member and the Vice President of NP2 since 2018. He has been Member of HIV Scientific Advisory Board at Ardea Biosciences Inc. since February 2008. Since 1989, Dr. Lalezari has served as a Principal Investigator for Phase 1, 2 and 3 clinical studies of new therapies for viral diseases including HIV/AIDS, CMV, HPV,& C, Influenza and RSV and COVID-19. Prior to joining Quest Clinical Research, Dr. Lalezari was Co-Director, HIV Clinical Research Center, Mt. Zion Medical Center at University of California, San Francisco. He has published several research papers and presented research at numerous international conferences. He received his board certification from the American Board of Internal Medicine. Dr. Lalezari holds a M.A. degree from the University of Virginia and earned his M.D. at the University of Pennsylvania. He also received a BA from the University of Rochester.
Positions
- Company NameCytoDyn Inc.Stock CodeCYDYPositionHead of Research and Translational SciencesColleagues
- RERobert E. HoffmanCEO & Principal Accounting Officer
- TDTanya Durkee UrbachIndependent Chairman of the Board
- TBTyler BlokChief Legal Officer & Corporate Secretary
- LWLauren WilcoxenCOO & Head of Regulatory Affairs
- RMRyan M. DunlapIndependent Director
- SMStephen M. SimesIndependent Director
- JBJonah B. SachaMember of Scientific Advisory Board
- HSHope S. RugoMember of Scientific Advisory Board
